Thioredoxin-1 expression regulated by morphine in SH-SY5Y cells

Neuroscience Letters

Volumn 523, Issue 1, 2012, Pages 50-55

  Luo, Fu Cheng ^a   Feng, Yue Mei ^a   Zhao, Lu ^a   Li, Kui ^a   Wang, Sheng Dong ^a   Song, Jun Ying ^a   Bai, Jie ^a  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Morphine; Opioid receptor; Thioredoxin 1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; OPIATE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; THIOREDOXIN 1; THIOREDOXIN INTERACTING PROTEIN;

APOPTOSIS; ARTICLE; CELL STRAIN; CELL STRAIN SH SY5Y; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANALGESICS, OPIOID; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MORPHINE; NEUROBLASTOMA; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, OPIOID; THIOREDOXINS;

EID: 84864306107     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.06.039     Document Type: Article

References (40)

1. Abdel-Zaher A.O., Abdel-Rahman M.S., FM E.L. Blockade of nitric oxide overproduction and oxidative stress by Nigella sativa oil attenuates morphine-induced tolerance and dependence in mice. Neurochemical Research 2010, 35:1557-1565.
2. Ammer H., Schulz R. Morphine dependence in human neuroblastoma SH-SY5Y cells is associated with adaptive changes in both the quantity and functional interaction of PGE1 receptors and stimulatory G proteins. Brain Research 1996, 707:235-244.
3. Bai J., Nakamura H., Kwon Y.W., Hattori I., Yamaguchi Y., Kim Y.C., Kondo N., Oka S., Ueda S., Masutani H., Yodoi J. Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells. Journal of Neuroscience 2003, 23:503-509.
4. Berhow M.T., Russell D.S., Terwilliger R.Z., Beitner-Johnson D., Self D.W., Lindsay R.M., Nestler E.J. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 1995, 68:969-979.
5. Bhalla S., Ciaccio N., Wang Z.J., Gulati A. Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells. Experimental Biology and Medical Science (Maywood) 2006, 231:1152-1156.
6. Bolanos C.A., Nestler E.J. Neurotrophic mechanisms in drug addiction. Neuromolecular Medicine 2004, 5:69-83.
7. Butler L.M., Zhou X., Xu W.S., Scher H.I., Rifkind R.A., Marks P.A., Richon V.M. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11700-11705.
8. Chae H.Z., Chung S.J., Rhee S.G. Thioredoxin-dependent peroxide reductase from yeast. Journal of Biological Chemistry 1994, 269:27670-27678.
9. Cui Y., Zhang X.Q., Xin W.J., Jing J., Liu X.G. Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of Rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats. Neuroscience 2010, 171:134-143.
10. Daijo H., Kai S., Tanaka T., Wakamatsu T., Kishimoto S., Suzuki K., Harada H., Takabuchi S., Adachi T., Fukuda K., Hirota K. Fentanyl activates hypoxia-inducible factor 1 in neuronal SH-SY5Y cells and mice under non-hypoxic conditions in a mu-opioid receptor-dependent manner. European Journal of Pharmacology 2011, 667:144-152.
11. Das K.C., Das C.K. Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions. Biochemical and Biophysical Research Communications 2000, 277:443-447.
12. Doyle T., Bryant L., Batinic-Haberle I., Little J., Cuzzocrea S., Masini E., Spasojevic I., Salvemini D. Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance. Neuroscience 2009, 164:702-710.
13. Endoh M., Kunishita T., Tabira T. Thioredoxin from activated macrophages as a trophic factor for central cholinergic neurons in vitro. Biochemical and Biophysical Research Communications 1993, 192:760-765.
14. Hirota K., Matsui M., Murata M., Takashima Y., Cheng F.S., Itoh T., Fukuda K., Yodoi J. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochemical and Biophysical Research Communications 2000, 274:177-182.
15. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. Journal of Biological Chemistry 1999, 274:27891-27897.
16. Hoshino Y., Nakamura T., Sato A., Mishima M., Yodoi J., Nakamura H. Neurotropin demonstrates cytoprotective effects in lung cells through the induction of thioredoxin-1. American Journal of Respiratory Cell and Molecular Biology 2007, 37:438-446.
17. Iglesias M., Segura M.F., Comella J.X., Olmos G. Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 2003, 44:482-492.
18. Khanna N.C., Sharma S.K. Megadoses of vitamin C prevent the development of tolerance and physical dependence on morphine in mice. Life Sciences 1983, 33(Suppl. 1):401-404.
19. Kim Y.C., Masutani H., Yamaguchi Y., Itoh K., Yamamoto M., Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. Journal of Biological Chemistry 2001, 276:18399-18406.
20. Kondo N., Nakamura H., Masutani H., Yodoi J. Redox regulation of human thioredoxin network. Antioxidants and Redox Signalling 2006, 8:1881-1890.
21. Lillig C.H., Holmgren A. Thioredoxin and related molecules-from biology to health and disease. Antioxidants and Redox Signalling 2007, 9:25-47.
22. Lin X., Wang Q., Ji J., Yu L.C. Role of MEK-ERK pathway in morphine-induced conditioned place preference in ventral tegmental area of rats. Journal of Neuroscience Research 2010, 88:1595-1604.
23. Luo F.C., Qi L., Lv T., Wang S.D., Liu H., Nakamura H., Yodoi J., Bai J. Geranylgeranylacetone protects mice against morphine-induced hyperlocomotion, rewarding effect, and withdrawal syndrome. Free Radic Biol Med 2012, 52:1218-1227.
24. Masutani H., Bai J., Kim Y.C., Yodoi J. Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection. Molecular Neurobiology 2004, 29:229-242.
25. Mouledous L., Diaz M.F., Gutstein H.B. Modulation of extracellular signal-regulated kinase (ERK) activity by acute and chronic opioid treatment in neuronal and glial cell lines. Journal of Neurochemistry 2004, 90:1371-1377.
26. Nakamura H. Extracellular functions of thioredoxin. Novartis Foundation Symposium 2008, 291:184-192. discussion 192-185, 221-184.
27. Nakamura H., Matsuda M., Furuke K., Kitaoka Y., Iwata S., Toda K., Inamoto T., Yamaoka Y., Ozawa K., Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunology Letters 1994, 42:75-80.
28. Nestler E.J. Common molecular and cellular substrates of addiction and memory. Neurobiology of Learning and Memory 2002, 78:637-647.
29. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends in Pharmacological Sciences 2004, 25:210-218.
30. Nestler E.J. Is there a common molecular pathway for addiction?. Nature Neuroscience 2005, 8:1445-1449.
31. Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. Journal of Biological Chemistry 1999, 274:21645-21650.
32. Pan J., Zhang Q., Zhang Y., Ouyang Z., Zheng Q., Zheng R. Oxidative stress in heroin administered mice and natural antioxidants protection. Life Sciences 2005, 77:183-193.
33. Raghavendra V., Tanga F.Y., DeLeo J.A. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 2004, 29:327-334.
34. Rehni A.K., Bhateja P., Singh T.G., Singh N. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Behavioural Pharmacology 2008, 19:265-269.
35. Salvemini D., Neumann W.L. Peroxynitrite: a strategic linchpin of opioid analgesic tolerance. Trends in Pharmacological Sciences 2009, 30:194-202.
36. Smith H.S. The role of genomic oxidative-reductive balance as predictor of complex regional pain syndrome development: a novel theory. Pain Physician 2010, 13:79-90.
37. Valjent E., Corbille A.G., Bertran-Gonzalez J., Herve D., Girault J.A. Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:2932-2937.
38. Yang J., Yu J., Jia X., Zhu W., Zhao L., Li S., Xu C., Yang C., Wu P., Lu L. Inhibition of nuclear factor-kappaB impairs reconsolidation of morphine reward memory in rats. Behavioural Brain Research 2011, 216:592-596.
39. Yu V.C., Eiger S., Duan D.S., Lameh J., Sadee W. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells. Journal of Neurochemistry 1990, 55:1390-1396.
40. Zhang X., Cui Y., Jing J., Xin W., Liu X. Involvement of p38/NF-kappaB signaling pathway in the nucleus accumbens in the rewarding effects of morphine in rats. Behavioural Brain Research 2011, 218:184-189.